Lansforsakringar Fondforvaltning’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Lansforsakringar Fondforvaltning's PFE Position: Q1 2026 in Review
Lansforsakringar Fondforvaltning increased its Pfizer (PFE) stake by 3.4% in Q1 2026, buying an estimated $2.76M and bringing the position to 3,158,825 shares worth $88.7M. The position accounts for 0.46% of the portfolio, ranked #36.
Lansforsakringar Fondforvaltning first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. The position peaked at $92.8M in Q4 2024. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Lansforsakringar Fondforvaltning held 3,158,825 shares of Pfizer worth $88.7M as of Q1 2026.
- Lansforsakringar Fondforvaltning bought 103,600 Pfizer shares in Q1 2026, an estimated $2.76M.
- Pfizer made up 0.46% of Lansforsakringar Fondforvaltning's portfolio in Q1 2026, its #36 holding.
- Lansforsakringar Fondforvaltning first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
- Lansforsakringar Fondforvaltning's Pfizer position peaked at $92.8M in Q4 2024.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Lansforsakringar Fondforvaltning's 13F filing for Q1 2026, filed 23 Apr 2026.